Form 4: 89bio, Inc. Executive Mansbach Reports Stock Transaction
SEC Form 4 Filing
Chief Medical Officer Harry H. Mansbach reports disposition of 1,050 shares of 89bio, Inc. stock to cover tax obligations.
Summary
- On February 17, 2025, Harry H. Mansbach, Chief Medical Officer of 89bio, Inc. (ETNB), disposed of 1,050 shares of common stock.
- The transaction was executed to cover estimated tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $10.57.
- Following the transaction, Mansbach directly owns 318,834 shares of 89bio, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider stock activity.
Key Dates
| Date | Description |
|---|---|
| 02/17/2025 | Date of stock transaction |
| 02/19/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, 89bio, Inc., ETNB, Harry H. Mansbach, Chief Medical Officer, Stock Transaction, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.